Stocks
Vanda Pharmaceuticals (VNDA) P/FCF US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 19.4 | 14.3 | 13.7 | 13.3 | 19.5 | -14.3 | |||
| Changes by years, y/y, % | -93% | -26% | -4% | -3% | +46% | -41.6% | |||
Vanda Pharmaceuticals. P/FCF
Vanda Pharmaceuticals. P/FCF, changes, %
Vanda Pharmaceuticals (VNDA) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/FCF | 9.72 | 19.6 | -20.2 | -59.5 | -15.0 | -14.3 | ||
| Changes by years, y/y, % | -15% | +46% | -408% | -733% | -254% | |||
| Changes by quarters, q/q, % | +4% | +101% | -203% | +195% | -75% | |||
